Barclays raised the firm’s price target on Comerica (CMA) to $66 from $56 and keeps an Underweight rating on the shares. The company’s Q3 earnings beat on better than expected expenses, provision and taxes, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA:
- Comerica says plans to repurchase $100M in common stock starting in Q4
- Morning Movers: CVS Health sinks following CEO change, weak guidance
- Options Volatility and Implied Earnings Moves Today, October 18, 2024
- Comerica reports Q3 EPS $1.33, consensus $1.16
- Comerica sees maintaining capital well above CET1 target of 10% through year-end